Welcome to our dedicated page for PTQQF news (Ticker: PTQQF), a resource for investors and traders seeking the latest updates and insights on PTQQF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PTQQF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PTQQF's position in the market.
Protech Home Medical will officially change its name to Quipt Home Medical on May 13, 2021, pending regulatory approvals. This rebranding is aimed at national expansion in the home respiratory care market. The company will also consolidate shares on a 1-for-4 basis and aims to list on the NASDAQ under the symbol QIPT. Trading will continue under PTQQF on OTCQX until the NASDAQ listing is completed, expected by late June 2021. This strategic move is designed to enhance market presence and facilitate organic growth through increased brand recognition.
Protech Home Medical Corp. (TSXV:PTQ; OTCQX:PTQQF) announced a webcasted presentation at the Sidoti Spring 2021 Investor Conference on March 24, 2021. The management team will host a presentation at 1:45 p.m. (ET) and participate in 1x1 meetings. The webcast will be accessible on the company's website and available for replay afterwards. Protech specializes in end-to-end respiratory care and aims to enhance its service offerings in chronic disease management to increase shareholder value.
Protech Home Medical Corp. (PTQQF) announced new locations in Daytona Beach, Florida, and Concord, New Hampshire, as part of its organic growth strategy. The Daytona Beach site aims to reduce logistical costs and enhance market reach, following the acquisition of Mayhugh's Medical Equipment, adding 10,000 active patients to its base. Protech has 120,000 active patients across 51 locations, with projected run-rate revenue between USD $100-$105 million. Management emphasizes plans for further expansion and acquisitions to strengthen its market position.
Protech Home Medical reported a 32% revenue growth in Q1 2021, reaching $22.8 million, compared to $17.2 million the previous year. Adjusted EBITDA rose 53% to $5.1 million with a margin of 22.5%. Recurring revenue constituted 75% of total revenue. The company announced a 160% increase in respiratory resupply set-ups and a 33% growth in unique patients served. Notably, Protech is targeting a listing on the NASDAQ and completed the acquisition of Mayhugh’s Medical Equipment, enhancing its patient base and market reach.
Protech Home Medical Corp. (TSXV:PTQ; OTCQX:PTQQF) announced plans to report Q1 Fiscal 2021 financial results in U.S. dollars starting March 2, 2021. This change aims to provide clarity by removing foreign exchange impacts for investors. The company is preparing for a NASDAQ listing, subject to regulatory approvals. CEO Greg Crawford highlighted ongoing efforts toward acquiring respiratory home care operators, emphasizing the potential to grow into a national provider within the U.S. healthcare market.
Protech Home Medical Corp. (PTQQF) is set to present at the MicroCap Rodeo Winter Wonderland Conference on February 16, 2021, at 3:30 PM (EST). CEO Greg Crawford will address a live virtual audience. The conference highlights 35 top investment opportunities recommended by qualified institutional investors. Protech specializes in in-home monitoring and disease management, focusing on respiratory solutions in the U.S. healthcare market. A recorded version of the presentation will be available on the company's website after the event.
Protech Home Medical Corp. (OTCQX: PTQQF) will host its Q4 and Full Year Fiscal 2020 earnings conference call on February 2, 2021, at 4:00 p.m. (EST). The call aims to discuss financial performance and growth strategies in the home medical equipment sector, focusing on respiratory care. Protech Home Medical provides in-home monitoring and disease management services, with a goal to expand offerings for chronic conditions. The company seeks to enhance shareholder value by increasing revenue per patient through integrating multiple services.
Protech Home Medical Corp. (PTQQF) reported significant growth in its Q4 2020 financial results, with revenue rising 28% year-over-year to $25 million and adjusted EBITDA increasing 69% to $5.9 million. For the full fiscal year, revenue reached $97.8 million, a 21% increase from 2019, while adjusted EBITDA grew 41% to $20.8 million. The customer base expanded by 20%, driven by technological advancements. Protech also plans to list on NASDAQ, enhancing visibility and growth potential.
Protech Home Medical Corp. (TSXV: PTQ, OTCQX: PTQQF) has been invited to present at the MicroCap Rodeo Best Ideas Bowl from October 13-16, 2020. The presentation is scheduled for October 14 at 11am EDT and will be webcast live. Protech focuses on end-to-end respiratory care and aims to expand services for chronic disease management in the U.S. healthcare market. CEO Greg Crawford expressed excitement about sharing the company’s success with U.S. investors and plans to keep shareholders informed about future conferences.
